Literature DB >> 15000154

Current and future trends in colorectal cancer screening.

Charles J Kahi1, Douglas K Rex.   

Abstract

Current modalities for colorectal cancer screening include fecal occult-blood testing, flexible sigmoidoscopy, colonoscopy, and double-contrast barium enema. Among these, colonoscopy is becoming the dominant modality, in light of its efficacy and continuing technical refinements. Emerging technologies, such as stool DNA tests and virtual colonoscopy, hold promise for the future but cannot be recommended for screening at present.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15000154     DOI： 10.1023/a:1025871231346

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN： 0167-7659            Impact factor:   9.264


  4 in total

1.  Temporal trends in incidence and mortality rates for colorectal cancer by tumor location: 1975-2007.

Authors:  Amanda I Phipps; John Scoggins; Mary Anne Rossing; Christopher I Li; Polly A Newcomb
Journal:  Am J Public Health       Date:  2012-01-19       Impact factor: 9.308

Review 2.  Changes in lipids composition and metabolism in colorectal cancer: a review.

Authors:  Alicja Pakiet; Jarosław Kobiela; Piotr Stepnowski; Tomasz Sledzinski; Adriana Mika
Journal:  Lipids Health Dis       Date:  2019-01-26       Impact factor: 3.876

3.  Untargeted LC-HRMS-based metabolomics to identify novel biomarkers of metastatic colorectal cancer.

Authors:  Ariadna Martín-Blázquez; Caridad Díaz; Encarnación González-Flores; Daniel Franco-Rivas; Cristina Jiménez-Luna; Consolación Melguizo; José Prados; Olga Genilloud; Francisca Vicente; Octavio Caba; José Pérez Del Palacio
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

4.  Proteomic Analyses of Fibroblast- and Serum-Derived Exosomes Identify QSOX1 as a Marker for Non-invasive Detection of Colorectal Cancer.

Authors:  Nicole Ganig; Franziska Baenke; May-Linn Thepkaysone; Kuailu Lin; Venkatesh S Rao; Fang Cheng Wong; Heike Polster; Martin Schneider; Dominic Helm; Mathieu Pecqueux; Adrian M Seifert; Lena Seifert; Jürgen Weitz; Nuh N Rahbari; Christoph Kahlert
Journal:  Cancers (Basel)       Date:  2021-03-17       Impact factor: 6.639
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.